AMRX - Amneal Pharmaceuticals Inc. (AMRX) Management Team on Q1 2022 Results - Earnings Call Transcript

Amneal Pharmaceuticals, Inc. (AMRX) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Tony DiMeo – Head-Investor Relations Chirag Patel – President and Co-Chief Executive Officer Chintu Patel – Co-Chief Executive Officer Tasos Konidaris – Chief Financial Officer Andy Boyer – Executive Vice President and Chief Commercial Officer-Generics Conference Call Participants Mikaela Franceschina – Barclays David Amsellem – Piper Sandler Gary Nachman – BMO Capital Markets Presentation Operator Hello and welcome to Amneal's First Quarter 2022 Conference Call. My name is Alex and I will be coordinating the call today. [Operator Instructions] I would now like to turn the call over to Amneal's Head of Investor Relations, Tony DiMeo. Over to you Tony? Tony DiMeo Good morning and thank you for joining Amneal's first quarter 2022 earnings call. Today, we issued a press release reporting our financial results. The press release and a presentation are available

For further details see:

Amneal Pharmaceuticals, Inc. (AMRX) Management Team on Q1 2022 Results - Earnings Call Transcript